Glucagon Market Outlook 2021 : [111 Pages Report] Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) to glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the proper level in healthy individuals. Glucagon is a medicine used to treat severe blood sugar levels (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The major global glucagon players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. The four main world manufacturers have a share of more than 80%. North America is the largest market, with a share close to 40%.
Market Insights and Analysis: Global Glucagon Market
In 2020, the global glucagon market size was USD 524 million and is expected to reach USD 793.2 million by the end of 2027, with a CAGR of 6.1% during 2021-2027.
The Final Report will add the analysis of the impact of COVID-19 on this industry.
TO UNDERSTAND HOW THE IMPACT OF COVID-19 IS COVERED IN THIS REPORT - REQUEST A SAMPLE
The Major Key Players of the Glucagon Market are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals
Opportunities for glucagon in the recent future is global glucagon market demand that is forecast to report strong consumption-driven development in major evolving markets. More growth opportunities emerge between 2021 and 2027 compared to a few years ago, signifying the rapid pace of change.
Get a sample PDF of the report - https://www.360researchreports.com/enquiry/request-sample/18902964
Glucagon Market Type Segment Analysis (Available market size for the years 2021-2027, Volume of consumption, Average price, Income, Market share and Trend 2015-2027):
- Inject glucagon, nasal glucagon
The main factors influencing the growth of the glucagon market is the increasing use of glucagon in emergency kits, general use, diagnostic and motility, cardiogenic shock and other industries.
The regions expected to dominate the glucagon market are North America, Europe, Asia-Pacific, South America, Middle East and Africa and others
If you have any questions about this report or are looking for a custom segment, application, region, or any other requirement, connect with an expert to customize the report.
Get a sample PDF of the report - https://www.360researchreports.com/enquiry/request-sample/18902964
For more related reports, click here:
